Skip to content

Diagnosis, treatment and prognosis of apical hypertrophic cardiomyopathy: Fujian study

Diagnosis, treatment and prognosis of apical hypertrophic cardiomyopathy: Fujian study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055251
Enrollment
Unknown
Registered
2022-01-04
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apical Hypertrophic Cardiomyopathy (AHCM)

Interventions

case series:None

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. AHCM patients diagnosed by 12-lead synchronous ECG and related imaging methods (Echocardiography, Cardiac Magnetic Resonance, Left Ventricular Angiography, Myocardial Perfusion Imaging) for outpatient and inpatient treatment in the First Affiliated Hospital of Fujian Medical University (our hospital); 2. Regardless of gender, aged 18-95 years; 3. The patient signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Cardiac hypertrophy due to hypertension, aortic stenosis, coarctation of the aorta, metabolic diseases, etc.; 2. Rheumatic immune system diseases; 3. Severe liver and kidney insufficiency; 4. Blood system diseases; 5. Acute and chronic infectious diseases; 6. Malignant tumor; 7. Long-term use of glucocorticoids; 8. Pregnancy; 9. Poor compliance.

Design outcomes

Primary

MeasureTime frame
electrocardiogram;left atrial diameter;left ventricular end-diastolic internal diameter;inter-ventricular septum thickness;left ventricular posterior wall thickness at end-systole;left ventricular posterior wall depth at end-diastole;left ventricular ejection fraction;left ventricular end-systolic volume;left ventricular end-diastolic volume;

Countries

China

Contacts

Public ContactXie Liangdi
ldxield@163.com+86 13509369323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026